eyelid disease: A disease involving the eyelid.
Disorders of eyelid in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_EYELIDINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1250 |
4. Check minimum number of eventsNone |
1250 |
5. Include endpointsNone |
1250 |
6. Filter based on genotype QC (FinnGen only) |
1250 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of eyelid in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Other disorders of eyelid
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9999 | 6105 | 3853 |
| Only index persons | 9236 | 5722 | 3514 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.17 | 0.11 |
| Only index persons | 0.18 | 0.21 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 50.95 | 52.09 | 48.97 |
| Only index persons | 49.55 | 51.01 | 47.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1250 | 826 | 424 |
| Unadjusted period prevalence (%) | 0.25 | 0.28 | 0.19 |
| Median age at first event (years) | 53.14 | 50.92 | 57.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1121
- Matched controls
- 11209
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
+∞
323.0
465
*
J05AB01
ATC
aciclovir; systemic
14.7
323.0
762
1418
S01AD03
ATC
aciclovir; ophthalmic
155.6
323.0
731
133
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
+∞
323.0
443
*
H03.1
ICD-10 Finland
Involvement of eyelid in other infectious diseases classified elsewhere
2582.3
238.2
222
*
J05AB11
ATC
valaciclovir; oral
9.5
190.8
455
752
B00.10
ICD-10 Finland
Herpes simplex facialis
60.5
106.1
124
23
B00.5
ICD-10 Finland
Herpesviral ocular disease
404.0
76.8
76
*
B02.3
ICD-10 Finland
Zoster ocular disease
119.6
72.9
78
7
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
39.8
61.9
78
21
H04.10
ICD-10 Finland
Dry eye syndrome
7.3
56.0
142
218
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.7
51.1
540
2901
L20.0
ICD-10 Finland
Besnier prurigo
5.3
51.0
167
356
D06BB03
ATC
aciclovir; topical
6.6
50.7
138
233
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
18.2
47.9
75
44
H13.1*B00.5
ICD-10 Finland
Herpesviral conjunctivitis
465.9
45.6
45
*
H03.1*B08.1
ICD-10 Finland
Involvement of eyelid in molluscum contagiosum
433.3
42.4
42
*
H01.0
ICD-10 Finland
Blepharitis
7.4
40.4
100
147
B02.9
ICD-10 Finland
Zoster without complication
5.1
37.0
124
268
D07AA02
ATC
hydrocortisone; topical
2.9
33.0
228
902
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.3
31.5
172
576
D11AH01
ATC
tacrolimus; topical
16.8
31.3
50
31
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
31.8
30.5
40
13
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
46.4
29.8
36
8
H02.3
ICD-10 Finland
Blepharochalasis
25.2
28.0
39
16
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
26.7
363
2030
E0000UV
ATC
NA
2.0
26.6
484
3057
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
26.1
397
2325
E000002
ATC
NA
2.9
26.0
179
696
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
14.3
26.0
44
32
D11AX14
ATC
[U] tacrolimus; topical
26.9
25.0
34
13
J01DB01
ATC
cefalexin; oral
2.2
23.6
919
7605
H03.8*L01.0
ICD-10 Finland
Involvement of eyelid in impetigo
+∞
20.9
20
*
B00.1
ICD-10 Finland
Herpesviral vesicular dermatitis
17.3
20.6
32
19
E000001
ATC
NA
2.1
20.0
264
1429
S01GX01
ATC
cromoglicic acid; ophthalmic
2.1
19.6
248
1315
R06AE07
ATC
cetirizine; oral
1.8
19.5
513
3573
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.5
18.9
92
280
J01DA01
ATC
[U] cefalexin; systemic
1.8
18.8
694
5356
B02
ICD-10 Finland
Zoster [herpes zoster]
4.4
18.8
69
164
D07AB08
ATC
desonide; topical
2.6
18.7
150
633
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
20.4
17.8
26
13
H13.1
ICD-10 Finland
Conjunctivitis in infectious and parasitic diseases classified elsewhere
96.6
17.6
19
*
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.3
17.6
170
795
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.4
17.5
165
761
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
3.6
17.4
81
238
D07AC13
ATC
mometasone; topical
1.9
17.3
339
2119
D07BC01
ATC
betamethasone and antiseptics; topical
2.4
15.7
146
667
H10.5
ICD-10 Finland
Blepharoconjunctivitis
7.2
15.4
37
53
H16.0
ICD-10 Finland
Corneal ulcer
3.8
15.4
66
182
F29
ICPC
Eye symptom/complaint other
2.8
15.1
99
371
H02AB06
ATC
prednisolone; systemic
1.7
15.0
495
3597
XQ800
NOMESCO Finland
Prick test
2.7
14.6
102
399
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
81.2
14.6
16
*
S71
ICPC
Herpes simplex
14.4
14.6
24
17
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
151.9
14.5
15
*
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
151.9
14.5
15
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.8
14.5
62
171
H16.9
ICD-10 Finland
Keratitis, unspecified
7.7
14.5
33
44
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
6.6
14.2
36
56
N05BB01
ATC
hydroxyzine; systemic
2.8
14.1
95
363
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
13.8
13.8
23
17
R06AX13
ATC
loratadine; oral
2.0
13.2
187
1025
D07AC01
ATC
betamethasone; topical
1.7
13.2
365
2500
D11AH02
ATC
pimecrolimus; topical
19.3
12.9
19
10
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
50.6
12.9
15
*
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.0
12.9
74
256
F01
ICPC
Eye pain
5.1
12.7
39
78
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
131.4
12.5
13
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
12.4
174
951
B02.8
ICD-10 Finland
Zoster with other complications
11.8
12.3
22
19
D11AX15
ATC
[U] pimecrolimus; topical
47.2
11.9
14
*
N03AX16
ATC
pregabalin; oral
1.8
11.9
240
1488
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
65.6
11.6
13
*
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
65.6
11.6
13
*
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
121.2
11.4
12
*
E000006
ATC
NA
2.5
11.3
92
393
H16.2
ICD-10 Finland
Keratoconjunctivitis
17.2
11.2
17
10
D07CC01
ATC
betamethasone and antibiotics; topical
2.0
11.1
153
826
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
60.6
10.6
12
*
R03AC02
ATC
salbutamol; inhalant
1.5
10.5
546
4306
E000003
ATC
NA
2.8
10.5
67
250
B00.0
ICD-10 Finland
Eczema herpeticum
10.7
10.3
19
18
N02BE01
ATC
paracetamol; systemic, rectal
1.7
10.3
911
8117
D02AX
ATC
Other emollients and protectives
3.3
10.2
50
156
R06AE09
ATC
levocetirizine; oral
1.9
10.1
160
909
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
10.1
109
534
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.6
9.9
73
295
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
9.9
100
473
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
26.3
9.8
13
5
H10.4
ICD-10 Finland
Chronic conjunctivitis
10.7
9.8
18
17
S01GX08
ATC
ketotifen; ophthalmic
3.2
9.6
50
163
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.6
380
2801
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.5
411
3087
R06AX22
ATC
ebastine; oral
1.8
9.5
187
1142
H02AB04
ATC
methylprednisolone; systemic
1.9
9.5
155
891
R01AD09
ATC
mometasone; nasal
1.5
9.4
455
3505
H03.1*A18.4
ICD-10 Finland
Lupus vulgaris: of eyelid
+∞
9.4
9
*
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
+∞
9.4
9
*
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
3.9
9.4
37
97
R06AX27
ATC
desloratadine; oral
1.6
9.3
285
1972
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
9.2
283
1958
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
3.1
9.2
49
163
H00.1
ICD-10 Finland
Chalazion
5.0
9.2
28
57
A02BC05
ATC
esomeprazole; systemic
1.5
9.1
396
2978
L20
ICD-10 Finland
Atopic dermatitis
3.8
9.0
37
101
G53.0
ICD-10 Finland
Postzoster neuralgia
10.8
8.8
16
15
H02.4
ICD-10 Finland
Ptosis of eyelid
10.8
8.8
16
15
R42
ICD-10 Finland
Dizziness and giddiness
1.7
8.8
215
1399
S01AX11
ATC
[U] ofloxacin; ophthalmic
3.1
8.7
45
147
H03.8
ICD-10 Finland
Involvement of eyelid in other diseases classified elsewhere
50.4
8.7
10
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
8.6
256
1752
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
8.5
173
1065
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.5
458
3585
D07AB01
ATC
clobetasone; topical
3.2
8.5
43
139
J01FF01
ATC
clindamycin; systemic
1.6
8.4
268
1864
H57.1
ICD-10 Finland
Ocular pain
3.5
8.4
38
112
M79.6
ICD-10 Finland
Pain in limb
1.5
8.2
353
2635
H02AB07
ATC
prednisone; oral
1.8
8.0
148
886
L04AA01
ATC
[U] ciclosporin; systemic
4.4
8.0
27
62
E000007
ATC
NA
2.3
7.9
68
301
F73
ICPC
Eye infection/inflammation other
4.3
7.9
28
67
D07AC14
ATC
methylprednisolone aceponate; topical
2.5
7.9
61
255
M54.5
ICD-10 Finland
Low back pain
1.5
7.7
327
2422
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.9
7.6
111
612
C01CA24
ATC
epinephrine; parenteral
2.3
7.6
70
317
H15.1
ICD-10 Finland
Episcleritis
4.5
7.6
25
56
L04AA06
ATC
mycophenolic acid; systemic
4.5
7.6
25
56
D07CB01
ATC
triamcinolone and antibiotics; topical
4.1
7.4
27
67
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.9
7.4
43
153
M01AE02
ATC
naproxen; oral, rectal
1.4
7.3
563
4674
R03BA01
ATC
beclometasone; inhalant
1.7
7.3
145
888
H02.1
ICD-10 Finland
Ectropion of eyelid
+∞
7.3
7
*
05403
ICD-8 Finland
Herpes simplex, Cutaneus (Eczema herpeticum)
+∞
7.3
7
*
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.7
7.3
30
83
H10
ICD-10 Finland
Conjunctivitis
2.3
7.2
65
293
M01AC06
ATC
meloxicam; systemic, rectal
1.5
7.1
353
2693
R03DC03
ATC
montelukast; oral
1.7
7.1
162
1029
CBB00
NOMESCO Finland
Excision of chalazion
20.2
7.1
10
5
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.1
361
2767
S01ED01
ATC
timolol; ophthalmic
2.9
7.1
41
145
R51.80
ICD-10 Finland
Headache
1.7
7.1
147
910
A46
ICD-10 Finland
Erysipelas
1.7
7.0
134
807
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.9
7.0
100
548
S70
ICPC
Herpes zoster
3.4
7.0
31
92
N03AX12
ATC
gabapentin; oral
1.7
6.9
143
885
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.9
405
3192
J01AA02
ATC
doxycycline; systemic
1.4
6.9
800
7122
L04AD01
ATC
ciclosporin; systemic
3.6
6.8
29
83
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.6
6.8
201
1370
B02.20
ICD-10 Finland
Herpes zoster trigeminal neuralgia
40.3
6.8
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.8
205
1405
S01GX02
ATC
levocabastine; ophthalmic
2.1
6.7
70
340
L04AA13
ATC
leflunomide; oral
3.3
6.7
32
100
J01FA01
ATC
erythromycin; systemic
1.7
6.7
144
898
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
6.7
278
2042
D07XB05
ATC
dexamethasone, combinations; topical
3.2
6.7
32
101
H01.9
ICD-10 Finland
Inflammation of eyelid, unspecified
6.5
6.6
16
25
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
7.9
6.6
14
18
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.6
276
2028
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
6.6
120
716
B00.11
ICD-10 Finland
Herpes simplex labialis
4.2
6.5
23
56
D02AE01
ATC
carbamide; topical
2.0
6.4
76
392
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
6.3
270
1993
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
6.3
93
517
B00.8
ICD-10 Finland
Other forms of herpesviral infection
18.1
6.3
9
5
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.3
220
1558
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
6.3
140
888
ZXA05
NOMESCO Finland
Left side
1.5
6.3
236
1699
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
6.2
269
1987
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
6.2
212
1493
J01FA10
ATC
azithromycin; systemic
1.4
6.1
579
4922
R06.0
ICD-10 Finland
Dyspnoea
1.5
6.1
229
1643
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
6.1
106
623
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
6.1
188
1289
A02BC01
ATC
omeprazole; systemic
1.5
6.1
261
1927
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
98
5.38
25.47
1.3
1.2
—
—
—
0
0
20
19
10.68
18.25
1.2
1.1
—
—
—
0
0
715
5719
1.58
13.88
10.4
8.6
4.2
4.1
e9/l
0.75
640
5027
868
7324
1.61
12.94
4.8
3.9
12.9
12.3
mm/h
0.54
808
6770
791
6555
1.56
12.53
5.7
4.3
1060.7
2354.9
e6/l
—
9
105
1106
10031
1.89
11.70
18.8
13.2
21.2
23.2
mg/l
1.39
890
7856
607
4813
1.51
11.30
4.5
3.5
0.0
0.0
estimate
0.00
117
917
606
4829
1.49
10.86
6.0
4.8
0.0
0.0
estimate
0.50
119
920
609
4879
1.48
10.50
4.5
3.6
0.0
0.0
estimate
0.80
115
889
876
7566
1.53
10.34
8.2
7.1
77.7
78.2
u/l
0.13
829
7083
528
4130
1.48
10.16
5.4
4.5
35.5
35.5
g/l
0.00
479
3838
21
44
4.84
9.56
1.3
1.2
—
—
—
0
0
773
6561
1.47
9.50
3.6
3.2
—
—
—
0
0
116
636
1.91
9.11
1.7
1.2
1512.9
195.3
u/ml
0.89
109
581
591
4801
1.44
8.96
8.0
6.5
1.2
1.2
mmol/l
0.35
501
4037
25
65
3.90
8.71
2.3
2.1
18.0
13.7
%
0.70
16
31
542
4352
1.43
8.66
7.0
5.9
1.2
1.2
mmol/l
0.21
494
3926
556
4497
1.43
8.48
3.5
2.7
111.0
114.0
ug/l
0.13
514
4164
113
635
1.86
8.23
2.1
1.6
—
—
—
0
0
474
3765
1.42
7.82
4.8
3.7
—
—
—
0
0
23
61
3.82
7.82
2.3
2.2
—
—
—
0
0
344
2578
1.46
7.79
5.2
3.9
0.0
0.0
estimate
1.08
117
901
1137
10634
1.77
7.70
11.9
9.7
25.7
25.6
u/l
0.05
1103
10246
439
3451
1.42
7.64
4.4
3.1
—
—
—
0
0
187
1244
1.59
7.37
8.4
5.2
1.1
1.0
mmol/l
0.17
175
1136
665
5634
1.39
7.35
5.3
4.7
6.6
6.7
mmol/l
0.51
628
5243
331
2486
1.45
7.34
2.4
2.1
3.2
3.0
mg/l
0.47
290
2095
49
211
2.38
7.21
1.5
1.5
—
—
—
0
0
605
5064
1.38
7.11
6.0
6.0
11.1
11.1
umol/l
0.01
573
4791
32
114
2.85
6.88
1.3
1.4
—
—
—
0
0
38
149
2.60
6.82
1.4
1.4
—
—
—
0
0
1097
10223
1.60
6.80
20.1
15.3
3.9
4.0
mmol/l
1.21
1074
9921
476
3854
1.38
6.77
2.1
2.0
99.1
95.2
pmol/l
0.99
262
2007
417
3305
1.39
6.74
3.5
3.4
2.4
2.4
mmol/l
0.12
363
2885
23
68
3.43
6.71
3.2
1.8
714.7
697.9
e6/l
—
6
27
31
111
2.84
6.61
1.3
1.4
—
—
—
0
0
245
1772
1.48
6.53
1.7
1.7
1158.6
1188.6
nmol/l
0.20
184
1325
296
2221
1.44
6.50
2.3
1.7
1.0
1.2
mg/l
0.41
220
1672
497
4084
1.36
6.33
2.4
2.3
79.2
77.0
nmol/l
0.96
455
3649
58
284
2.09
6.31
1.3
1.2
—
—
—
0
0
448
3623
1.37
6.31
4.4
3.4
31.9
47.9
ng/l
0.81
288
2408
57
280
2.09
6.16
1.3
1.2
—
—
—
0
0
166
1119
1.56
6.16
7.2
7.1
104.5
104.2
mmol/l
0.28
159
1089
34
133
2.60
6.15
1.3
1.4
—
—
—
0
0
242
1767
1.46
6.12
3.6
2.9
2.5
2.4
mmol/l
0.38
202
1555
316
2424
1.41
6.09
3.2
2.5
6540.9
6895.4
umol/l
0.05
276
2100
1090
10195
1.54
6.06
20.0
15.2
139.5
139.6
mmol/l
1.20
1067
9912
871
7827
1.37
6.04
4.5
4.0
14.8
14.7
pmol/l
0.49
792
7147
250
1841
1.45
6.04
1.7
1.5
—
—
—
0
0
1005
9260
1.44
5.94
5.3
4.8
1.9
2.0
mu/l
0.59
931
8494
269
2015
1.43
5.91
3.3
2.5
5.8
6.9
e6/l
0.33
236
1764
46
212
2.21
5.84
1.5
1.5
—
—
—
0
0
32
125
2.60
5.82
1.5
1.4
—
—
—
0
0
49
233
2.15
5.77
1.8
1.8
8659.0
14791.8
e6/l
1.02
40
175
1010
9349
1.42
5.51
15.3
12.2
81.0
82.0
ml/min/173m2
0.70
844
7640
375
3003
1.36
5.47
2.8
2.4
65.4
56.0
u/l
0.80
343
2786
335
2642
1.37
5.37
3.8
3.1
1717.3
1462.6
ng/l
0.56
292
2239
36
158
2.32
5.15
1.6
1.5
—
—
—
0
0
1171
11210
1.71
5.07
26.9
19.5
6.9
6.8
e9/l
0.31
1146
10896
336
2672
1.35
5.07
4.0
2.9
0.3
0.4
e6/l
0.93
262
2001
1170
11199
1.70
5.06
27.0
19.5
256.6
254.1
e9/l
0.67
1146
10918
119
780
1.58
4.99
12.4
7.3
9.4
9.7
mmol/l
0.20
112
737
1170
11207
1.69
4.94
26.9
19.5
4.5
4.5
e12/l
0.66
1145
10901
50
256
1.99
4.89
1.5
1.4
—
—
—
0
0
1170
11211
1.68
4.88
27.1
19.6
133.6
134.4
g/l
1.20
1157
11037
205
1521
1.42
4.69
2.2
1.8
—
—
—
0
0
356
2888
1.33
4.64
2.3
2.0
139.9
229.6
u/l
1.76
336
2719
286
2256
1.35
4.49
1.4
1.3
0.8
1.7
u/ml
1.95
66
583
70
412
1.74
4.46
1.5
2.1
41.2
40.0
u/l
0.18
62
367
200
1491
1.41
4.45
2.9
2.4
12.5
13.1
umol/l
0.53
185
1371
16
50
3.23
4.34
1.4
1.5
10.4
15.1
u/l
1.71
16
45
211
1600
1.38
4.24
3.1
2.6
1.1
1.2
e6/l
0.05
134
889
541
4698
1.27
4.06
4.4
4.0
—
—
—
0
0
148
1064
1.44
4.03
2.3
1.7
—
—
—
0
0
112
763
1.51
3.99
4.8
3.5
92.6
82.5
ng/l
0.52
90
663
110
750
1.51
3.90
1.7
2.9
66.0
67.0
g/l
0.74
100
679
144
1040
1.43
3.83
5.2
4.0
230.5
253.9
u/l
1.24
137
981
735
6644
1.26
3.82
3.2
2.9
44.6
45.7
u/l
0.15
686
6205
49
274
1.82
3.75
3.1
2.8
—
—
—
0
0
165
1229
1.39
3.69
2.0
2.1
—
—
—
0
0
163
1213
1.40
3.66
2.5
2.2
108.6
116.0
ug/g
0.15
127
956
23
97
2.40
3.66
1.8
1.4
—
—
—
0
0
27
123
2.22
3.62
1.0
1.1
—
—
—
0
0
26
118
2.23
3.52
1.4
1.3
—
—
—
0
0
180
1372
1.36
3.50
3.0
2.3
2.3
2.3
g/l
0.24
168
1267
144
1059
1.41
3.47
2.2
1.7
—
—
—
0
0
150
1111
1.40
3.47
2.0
2.0
—
—
—
0
0
207
1617
1.34
3.43
1.4
1.3
10.0
13.0
u/ml
0.36
76
634
276
2248
1.29
3.38
1.6
1.5
20.0
20.7
nmol/l
0.35
246
1904
262
2120
1.30
3.37
6.0
3.9
1.0
1.0
kg/l
0.02
36
310
14
48
2.94
3.30
2.5
2.9
654.2
1079.5
u/ml
0.64
14
48
66
417
1.62
3.30
3.8
2.6
0.7
0.7
%
0.01
60
403
124
897
1.42
3.29
2.6
2.3
31.2
37.1
u/l
0.92
107
748
228
1820
1.31
3.24
1.4
1.4
—
—
—
0
0
123
893
1.42
3.20
2.1
2.0
359.4
374.0
nmol/l
0.41
114
819
995
9401
1.29
3.19
4.0
3.8
1.3
1.3
mmol/l
0.07
914
8599
1048
9970
1.32
3.19
5.0
4.6
2.8
2.8
mmol/l
0.15
964
9174
35
186
1.91
3.17
2.5
2.3
15.0
16.2
%
0.88
14
93
154
1165
1.37
3.15
25.9
23.6
1.3
1.3
inr
0.15
17
149
304
2529
1.27
3.12
1.7
1.6
1.3
1.4
mmol/l
0.40
259
2138
31
159
1.97
3.11
1.2
1.0
1.9
3.3
u/ml
0.45
11
40
23
105
2.21
3.10
1.5
1.5
—
—
—
0
0
45
261
1.75
3.10
1.5
1.3
—
—
—
0
0
1031
9796
1.30
3.10
4.6
4.2
4.7
4.7
mmol/l
0.13
955
9068
111
797
1.43
3.08
4.9
3.4
1.2
1.2
mmol/l
0.04
100
678
189
1481
1.33
3.06
4.2
3.3
0.8
0.8
mmol/l
0.11
176
1381
270
2220
1.28
3.05
5.0
4.9
17.6
3.0
ug/l
0.50
249
1983
146
1101
1.37
3.05
3.3
2.6
4.8
7.9
umol/l
5.58
129
944
1012
9602
1.28
3.01
4.7
4.3
5.9
5.9
mmol/l
0.07
936
8736
166
1281
1.34
2.99
3.2
2.4
21.4
22.7
%
0.73
139
1099
16
63
2.56
2.96
1.5
1.5
—
—
—
0
0
211
1694
1.30
2.87
1.4
1.3
28.5
29.7
iu/ml
0.06
64
560
984
9323
1.26
2.84
18.8
14.4
39.2
39.6
%
0.54
712
6809
22
104
2.14
2.75
1.0
1.3
66.4
51.5
u/l
0.55
15
73
20
91
2.22
2.74
1.6
1.5
—
—
—
0
0
901
8471
1.23
2.70
22.6
16.2
13.7
13.7
%
0.47
886
8282
282
2371
1.24
2.61
2.6
2.3
—
—
—
0
0
1021
9741
1.26
2.61
4.5
4.2
1.5
1.5
mmol/l
0.14
941
8963
21
100
2.12
2.59
1.5
1.4
21300.0
106000.1
e6/l
0.64
16
69
6
11
5.48
2.54
2.5
4.5
—
—
—
0
0
115
862
1.37
2.52
5.9
3.5
1.8
1.9
mmol/l
0.04
98
679
58
383
1.54
2.47
1.8
1.6
326.1
313.8
mu/l
0.08
51
348
26
138
1.90
2.42
1.3
1.1
—
—
—
0
0
18
83
2.19
2.41
1.6
1.1
—
—
—
0
0
18
83
2.19
2.41
1.6
1.5
22.5
31.2
%
0.50
12
56
186
1507
1.28
2.36
3.3
2.7
4.1
3.2
e6/l
0.37
107
804
215
1776
1.25
2.32
4.1
4.1
22.4
21.7
%
0.29
101
824
81
583
1.42
2.27
7.5
7.3
24.3
24.5
mmol/l
0.23
76
550
6
13
4.63
2.27
1.3
1.6
—
—
—
0
0
17
79
2.17
2.25
1.2
1.4
—
—
—
0
0
17
79
2.17
2.25
1.2
1.4
—
—
—
0
0
17
79
2.17
2.25
1.2
1.4
—
—
—
0
0
19
93
2.06
2.22
4.1
3.7
—
—
—
0
0
102
769
1.36
2.18
3.0
2.4
5.2
6.9
ug/l
0.58
87
680
47
306
1.56
2.16
1.7
1.7
—
—
—
0
0
60
413
1.48
2.14
5.1
3.4
54.6
48.6
%
1.05
60
406
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
291
1.57
2.13
3.8
3.0
0.3
0.4
u/ml
0.56
27
158
12
49
2.46
2.10
1.2
1.3
8.1
12.2
u/l
1.40
12
43
944
8996
1.20
2.08
6.2
5.4
39.4
39.6
mmol/mol
0.29
874
8345
14
62
2.27
2.08
1.0
1.2
—
—
—
0
0
52
350
1.51
2.07
1.1
2.4
7.3
7.5
g/l
0.15
37
271
34
208
1.65
2.02
1.6
2.2
124.3
129.2
g/l
0.60
20
155
114
885
1.32
2.02
2.0
2.2
0.2
0.2
g/l
0.00
108
830
45
296
1.54
2.00
1.4
1.6
0.2
0.1
iu/ml
—
10
54
49
329
1.51
1.99
1.1
2.5
3.0
3.2
g/l
0.62
36
263
96
730
1.34
1.97
2.5
2.6
70.6
68.2
ml/min/173m2
0.23
44
299
32
195
1.66
1.94
1.2
1.3
—
—
—
0
0
32
195
1.66
1.94
1.2
1.3
—
—
—
0
0
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
51
349
1.48
1.90
1.1
2.5
3.8
3.9
g/l
0.03
35
259
51
350
1.48
1.88
1.1
2.4
—
—
—
0
0
21
114
1.86
1.88
1.7
1.6
69.4
58.9
%
0.62
11
82
30
182
1.66
1.86
3.2
3.3
4.3
4.3
e9/l
0.04
30
182
40
261
1.55
1.86
1.5
1.3
—
—
—
0
0
16
79
2.04
1.85
1.3
1.2
1.8
1.5
nmol/l
0.55
16
67
132
1059
1.28
1.84
5.5
8.2
0.9
1.2
mmol/l
0.43
101
818
14
66
2.13
1.82
1.6
1.6
1.7
7.5
u/l
—
8
31
31
191
1.64
1.82
3.4
3.5
54.7
58.9
%
0.80
31
191
209
1770
1.22
1.80
5.3
3.7
380.1
465.2
ng/l
0.14
150
1319
93
714
1.33
1.80
1.9
1.9
—
—
—
0
0
7
23
3.05
1.80
1.0
1.1
77.1
102.8
%
—
7
23
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
55
388
1.44
1.77
1.4
1.5
—
—
—
0
0
50
348
1.45
1.73
3.8
3.1
145.0
1022.1
u/ml
1.02
39
301
5
13
3.86
1.71
3.8
2.5
62.0
66.5
pmol/l
—
5
13
5
13
3.86
1.71
1.2
1.2
1.2
1.7
umol/24h
—
5
13
42
284
1.50
1.68
5.4
3.7
4.0
3.8
mmol/l
1.10
37
259
31
197
1.59
1.63
1.2
1.1
2.1
2.3
u/ml
0.05
21
78
130
1058
1.26
1.63
5.6
8.2
12.1
12.1
kpa
0.04
124
1015
61
446
1.39
1.63
7.1
3.9
24.2
24.0
mmol/l
0.31
54
403
27
166
1.64
1.62
1.1
1.3
—
—
—
0
0
42
288
1.47
1.59
1.7
3.7
27.2
51.2
mg/l
1.29
34
239
44
305
1.46
1.58
1.2
2.7
0.0
1.1
g/l
4.77
37
267
11
50
2.21
1.57
1.5
1.3
33.6
36.0
nmol/l
0.09
11
40
75
571
1.33
1.57
1.8
1.7
—
—
—
0
0
16
85
1.89
1.55
2.1
2.3
—
—
—
0
0
25
153
1.65
1.54
4.0
5.5
345.8
366.1
umol/l
0.29
19
133
24
146
1.66
1.51
1.3
1.1
—
—
—
0
0
21
123
1.72
1.51
1.6
1.3
38.6
0.6
nmol/l
0.48
21
116
46
325
1.43
1.51
1.1
2.5
10.2
10.5
g/l
0.21
36
280
11
51
2.17
1.50
1.2
1.4
—
—
—
0
0
6
21
2.87
1.50
1.5
1.1
—
—
—
0
0
28
178
1.59
1.49
1.4
1.2
243.1
249.3
u/ml
0.05
20
100
30
194
1.56
1.49
1.4
1.4
—
—
—
0
0
21
124
1.71
1.47
1.6
1.3
—
0.6
nmol/l
—
0
9
37
252
1.48
1.46
2.4
1.7
3.0
5.1
iu/l
1.60
12
83
236
2065
1.18
1.44
1.7
1.7
450.3
27944184.7
pmol/l
2.05
195
1707
29
188
1.56
1.43
1.4
1.2
—
—
—
0
0
36
246
1.48
1.41
1.2
1.2
9.0
16.7
u/ml
—
7
40
37
255
1.46
1.39
1.2
1.1
—
—
—
0
0
19
111
1.72
1.39
1.2
1.0
2.0
0.8
u/ml
—
10
28
154
1301
1.21
1.39
3.2
2.8
0.7
0.8
ug/l
0.46
106
833
71
548
1.31
1.38
1.4
1.4
—
—
—
0
0
41
289
1.43
1.38
1.8
3.7
179.6
75.0
mg/l
0.54
33
239
6
23
2.62
1.37
1.5
1.2
—
—
—
0
0
40
282
1.43
1.35
1.8
3.6
1.6
1.9
ratio
—
5
27
9
42
2.15
1.33
1.4
1.6
36.5
29.8
umol/l
—
9
42
92
739
1.26
1.33
3.9
2.9
194.8
208.3
ng/l
0.10
84
675
53
396
1.35
1.29
2.5
2.1
8026.6
3683.9
u/l
0.49
25
168
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
59
449
1.33
1.28
4.3
3.0
25.7
25.2
mmol/l
0.48
59
430
68
529
1.30
1.27
1.3
1.4
28.3
28.6
iu/l
0.03
61
455
73
574
1.29
1.26
3.2
3.8
1.5
1.8
mmol/l
0.44
53
441
73
575
1.29
1.24
1.8
1.5
—
—
—
0
0
20
123
1.64
1.24
1.3
1.0
14.2
4.8
u/ml
0.57
11
50
137
1160
1.20
1.23
9.8
6.6
—
—
—
0
0
115
957
1.22
1.23
3.8
4.2
17.7
20.7
ug/l
0.08
86
774
38
272
1.41
1.20
1.7
1.4
298.0
285.0
ug/g
0.16
24
161
39
281
1.40
1.19
1.5
1.6
—
—
—
0
0
39
281
1.40
1.19
1.2
2.5
38.4
37.4
g/l
0.48
31
245
44
324
1.37
1.19
1.1
1.3
143.3
227.4
miu/ml
0.95
16
159
6
26
2.31
1.18
1.2
2.0
—
—
—
0
0
8
38
2.11
1.18
1.3
1.5
—
—
—
0
0
78
626
1.26
1.16
4.2
3.2
4.3
4.6
pmol/l
1.80
72
550
8
39
2.06
1.15
1.3
1.5
—
—
—
0
0
27
183
1.49
1.14
1.9
1.7
—
—
—
0
0
51
389
1.32
1.11
1.2
1.5
—
—
—
0
0
21
135
1.57
1.11
1.2
1.0
9.1
2.8
u/ml
0.78
12
49
45
337
1.35
1.11
5.2
3.8
1.2
1.3
mmol/l
0.92
45
332
7
31
2.26
1.10
1.0
1.1
586.4
218.0
iu/ml
—
7
31
21
136
1.55
1.09
2.5
3.3
2.3
1.3
%
0.20
16
115
7
34
2.06
1.03
2.3
2.4
—
—
—
0
0
7
34
2.06
1.03
2.3
2.4
—
—
—
0
0
10
53
1.89
1.01
1.1
1.3
—
—
—
0
0
22
147
1.51
1.01
1.0
1.1
1.0
120.9
iu/ml
—
6
31
27
189
1.44
0.99
1.2
2.0
0.9
0.8
nmol/l
0.21
22
158
309
2831
1.12
0.99
4.1
4.0
8.3
8.9
mg/mmol
0.13
200
1782
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
7
36
1.95
0.97
1.1
1.1
0.3
0.3
g/l
—
7
30
74
606
1.24
0.96
3.3
3.7
5.0
5.2
kpa
1.25
67
572
30
216
1.40
0.96
1.5
1.5
63.0
539.9
e6/l
0.83
21
180
30
216
1.40
0.96
1.4
1.4
6.0
12.6
e6/l
0.53
21
176
77
926
0.82
0.93
1.7
1.6
—
—
—
0
0
6
28
2.15
0.91
3.0
1.9
—
—
—
0
0
352
3267
1.11
0.89
3.3
3.1
30.3
32.5
u/l
0.57
329
3109
8
44
1.82
0.86
1.4
1.3
—
—
—
0
0
12
72
1.67
0.85
2.6
1.8
—
—
—
0
0
8
45
1.78
0.84
1.7
2.1
—
—
—
0
0
22
154
1.44
0.83
1.2
1.1
—
—
—
0
0
21
147
1.44
0.80
1.3
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
2.1
—
7.5
—
0
13
30
225
1.34
0.78
2.4
2.2
177.5
116.7
ug/min
0.41
19
140
315
2927
1.10
0.78
3.8
3.1
7.6
7.4
mmol/l
0.30
274
2463
67
558
1.21
0.77
2.2
1.7
—
—
—
0
0
87
743
1.18
0.77
1.4
1.2
130.7
147.0
iu/ml
0.18
34
289
10
59
1.70
0.76
1.0
1.2
12.5
14.9
u/l
—
10
52
30
227
1.33
0.75
1.9
1.6
—
—
—
0
0
9
56
1.61
0.72
1.3
1.3
—
—
—
0
0
29
220
1.33
0.72
1.9
1.5
—
—
—
0
0
7
40
1.75
0.71
1.0
1.1
1582.1
1561.1
miu/ml
—
7
40
5
26
1.93
0.70
1.4
1.1
—
—
—
0
0
9
58
1.56
0.70
1.2
1.4
—
—
—
0
0
9
58
1.56
0.70
1.2
1.4
—
—
—
0
0
17
118
1.45
0.69
1.2
1.2
—
—
—
0
0
10
61
1.64
0.68
1.0
1.2
59.3
75.1
u/l
—
10
55
10
61
1.64
0.68
1.0
1.2
—
—
—
0
0
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
24
179
1.35
0.67
2.0
1.6
—
—
—
0
0
7
43
1.63
0.67
1.4
1.6
—
1130710.0
—
0
5
11
70
1.58
0.65
1.2
1.1
—
89.0
—
0
10
10
62
1.62
0.65
1.7
1.2
—
—
—
0
0
46
379
1.22
0.62
1.9
1.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
62
530
1.18
0.58
1.1
1.0
—
—
—
0
0
42
346
1.22
0.58
1.8
1.7
—
—
—
0
0
37
301
1.24
0.57
1.5
1.6
—
—
—
0
0
6
38
1.58
0.54
1.2
1.1
108.2
110.7
%
—
6
32
108
969
1.13
0.54
5.1
3.2
—
—
—
0
0
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
55
473
1.17
0.50
6.0
10.9
24.4
24.3
mmol/l
0.07
48
442
25
198
1.27
0.49
4.0
3.2
0.8
0.9
nmol/l
0.07
20
150
11
77
1.43
0.45
1.2
1.2
—
—
—
0
0
11
77
1.43
0.45
1.2
1.2
—
—
—
0
0
10
69
1.45
0.44
1.3
1.1
—
—
—
0
0
16
121
1.33
0.44
1.4
1.1
—
—
—
0
0
13
95
1.37
0.43
2.0
2.7
—
—
—
0
0
9
128
0.70
0.43
1.0
1.1
—
—
—
0
0
11
78
1.41
0.43
1.2
1.2
—
—
—
0
0
11
78
1.41
0.43
1.2
1.2
—
—
—
0
0
11
78
1.41
0.43
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
8
61
1.31
0.39
1.5
1.5
—
—
—
0
0
13
97
1.34
0.39
2.8
2.9
22.2
54.1
u/ml
1.03
13
97
15
193
0.77
0.39
2.9
4.0
90.9
29.2
u/ml
0.54
15
188
10
71
1.41
0.39
1.8
1.5
—
—
—
0
0
5
36
1.39
0.38
1.2
1.3
—
—
—
0
0
59
526
1.13
0.36
1.6
1.5
—
—
—
0
0
19
232
0.82
0.34
4.9
3.5
22.1
25.4
mg/l
—
9
148
6
86
0.70
0.33
1.0
1.0
—
—
—
0
0
24
201
1.20
0.32
1.3
1.4
—
—
—
0
0
62
560
1.11
0.32
2.6
2.1
10.3
12.3
nmol/l
1.20
53
498
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
30
259
1.16
0.30
1.6
1.5
—
—
—
0
0
7
57
1.23
0.29
1.0
1.3
—
—
—
0
0
45
403
1.12
0.28
1.6
1.7
3.5
4.3
mg/l
0.18
34
274
43
384
1.12
0.28
1.8
1.8
—
—
—
0
0
8
64
1.25
0.27
1.5
1.2
—
—
—
0
0
8
65
1.23
0.27
1.5
1.2
—
—
—
0
0
5
73
0.68
0.26
1.0
1.5
1.0
1.0
g/l
—
5
73
108
1148
0.94
0.25
2.0
1.7
1.4
1.4
%
0.21
96
1025
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
24.0
—
0
7
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
0.8
—
0
13
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
6
48
1.25
0.20
1.0
1.4
—
25.7
—
0
7
34
307
1.11
0.20
1.4
2.0
—
—
—
0
0
19
165
1.15
0.19
1.2
1.4
34.6
23.8
u/l
0.65
13
133
38
347
1.10
0.19
1.5
1.4
—
—
—
0
0
7
63
1.11
0.17
1.0
1.3
4.4
7.2
u/l
—
7
55
18
158
1.14
0.16
1.4
1.2
3.5
6.4
u/ml
0.62
11
65
7
88
0.79
0.14
2.0
1.3
—
—
—
0
0
32
299
1.07
0.11
1.5
1.3
—
—
—
0
0
21
193
1.09
0.10
1.6
1.5
—
—
—
0
0
5
45
1.11
0.10
1.0
1.2
—
83.0
—
0
6
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
6
56
1.07
0.08
1.3
1.4
—
—
—
0
0
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
5
64
0.78
0.08
9.8
2.0
—
—
—
0
0
6
75
0.80
0.07
1.2
1.1
263.7
289.2
mg/l
—
6
67
117
1194
0.98
0.06
4.4
4.4
33.0
32.4
%
0.22
87
798
15
161
0.93
0.05
1.1
1.2
18.9
29.8
u/l
0.60
15
144
12
130
0.92
0.04
1.6
1.4
—
—
—
0
0
12
130
0.92
0.04
1.6
1.4
—
—
—
0
0
28
291
0.96
0.04
1.5
1.4
—
—
—
0
0
12
128
0.94
0.02
1.6
1.4
—
—
—
0
0
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
12
127
0.94
0.01
1.6
1.4
—
—
—
0
0
12
127
0.94
0.01
1.6
1.4
—
—
—
0
0
12
127
0.94
0.01
1.6
1.4
—
—
—
0
0
14
133
1.05
0.01
1.1
1.1
—
—
—
0
0
27
277
0.97
0.01
1.2
1.2
—
—
—
0
0
11
104
1.06
0.01
1.4
6.0
5.8
7.7
mmol/l
2.81
11
83
10
98
1.02
0.00
1.2
1.1
—
—
—
0
0
16
158
1.01
0.00
1.4
1.2
9.3
3.3
u/ml
—
6
49
29
292
0.99
0.00
1.4
1.4
—
—
—
0
0
29
291
1.00
0.00
1.4
1.4
—
—
—
0
0
12
117
1.03
0.00
2.3
2.1
27.6
29.1
mg/l
—
5
31
0
9
0.00
0.00
0.0
6.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
31
310
1.00
0.00
1.5
1.5
—
—
—
0
0
29
290
1.00
0.00
1.4
1.4
—
—
—
0
0
11
110
1.00
0.00
1.1
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_EYELIDINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_EYELIDINOTH | 1.064 [0.96, 1.18] | 0.229 |
| Birth year | 0.992 [0.98, 1.0] | 0.059 |
During the follow-up period (1.1.1998 — 31.12.2019), 1091 out of 5713 females with H7_EYELIDINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_EYELIDINOTH | 1.126 [1.0, 1.27] | 0.055 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 819 out of 3615 males with H7_EYELIDINOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_EYELIDINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.085% | 0.236% |
| 5 | 0.602% | 1.414% |
| 10 | 1.425% | 3.493% |
| 15 | 2.699% | 6.594% |
| 20 | 4.826% | 11.058% |
Relationships between endpoints
↥Index endpoint: H7_EYELIDINOTH – Disorders of eyelid in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data